Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma (BiovaxID)

This study is ongoing, but not recruiting participants.
Information provided by Biovest International

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Non-Hodgkins Lymphoma
2		Additional conditions recognized in this trial
			Lymphoma
			Lymphoma, Follicular
			Lymphoma, Non-Hodgkin
3		More general conditions related to this trial
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphatic Diseases
			Lymphoproliferative Disorders
			Neoplasms
			Neoplasms by Histologic Type
4		Interventions listed in this trial
			tumor specific immune response
			control vaccine
5		Sponsors listed in this trial
			Biovest International